March/April 2008
Medical Device Technology
Selected Contents
MATERIALS
Material Matters Column: Technologies of Heart Transplantation
David Williams
It is now 40 years since the world's first heart transplant was performed at the Groote Schuur Hospital in Cape Town, South Africa. It is interesting to assess just how far heart transplantation has come since then.
In Vitro Biocompatibility Testing of Biomaterials and Medical Devices
U. Müller
Biomaterials used for medical devices must be thoroughly tested according to ISO 109931 before their introduction so that any negative effects on the body are known about and prevented. By using in vitro laboratory tests, dangers for patients and unnecessary animal experiments can be avoided. Here, in vitro tests for cell compatibility (cytotoxicity) and blood compatibility (haemocompatibility) are described.
DESIGN
A Microfluidics Platform for In Vitro Testing
T. Viegers, E. Pelssers, E. Lenders
A microfluidics system, together with a novel biosensor based on magnetic actuation of colloidal particles, enables the production of handheld diagnostic testing devices. Using this technology, a disposable diagnostic tester with short bioassay times for drugs of abuse has been developed as well as a platform to produce disposable devices for several other applications.
System-On-Chip Solutions For Portable Medical Devices
D. Manic, D. Severac, M. Morgan, and J.-P. Dan
A dedicated system-on-chip (SoC) integrates as much functionality as possible in a single chip and thereby allows miniaturisation of portable medical systems, while optimising performance and power consumption. Today's feature-rich semiconductor process technology platforms mean that SoC based solutions also optimise the cost and reliability of the overall system by reducing the number of components that are employed.
The Interface of Medical Devices and Pharmaceuticals: Part I
S.L. Willis and A.L. Lewis
This two-part article considers the complexities of developing and commercialising combination products using examples from experience with drug-eluting stents and drug-eluting beads. Part I discusses the technical challenges of developing these products.
Nanomedicine: Visionary Dreaming or Less of the Same
R. Moore
Some suggest that there is no such thing as nanotechnology and that it is only what scientists have been doing for a long time. This argument and some of the fact and fiction surrounding nanotechnology are assessed.
MANUFACTURING
X-Ray Sterilisation
J. Meissner
Radiation sterilisation of medical products has traditionally been done with gamma rays from radioactive sources or with electron beams produced by accelerators. Both methods sterilise by destroying microorganisms with ionising radiation. High energy X-rays sterilise in the same way. X-ray sterilisation is still a young process, however, considerable industrial experience has been gained through its post 9/11 use for sterilising large quantities of mail.
Identifying Packaging Errors
R.E. Hall
Common medical device packaging problems are identified here together with their cause and the remedy. The discussion examines the causes of poor heat seal, misleading results from the measurement of seal strength, blister flange curl, damage to sterile barrier system and failure of the ethylene oxide sterilisation process.
Developments in Radiation Sterilisation
R. Brinston, A. Miller, C. Deeley
This article outlines significant recent developments in radiation sterilisation and some of the initiatives currently underway. These include work on a method for sterilising combination products and revisions to several sterilisation guidelines, including those for selecting appropriate sterility assurance levels.
Faster Medical Devices
J. Tumelty
Advances in design-to-manufacture technology have led to shorter product development cycles and more online manufacturability analysis is on the way to further reduce the number of design iterations.
Packaging: Process Reliability Through Qualification and Validation
M. Ehrat, J. Steinbauer, and H. Wegmann
Today's packaging machines are built to help their operators achieve process reliability and qualification packages simplify the procedures for demonstrating it.
REGULATION & STANDARDS
Who Owns the 510(k)?
Maria Donawa
Unfortunately, some medical device manufacturers, particularly those based outside the United States (US) are unaware of the business implications of submitting a 510(k) premarket notification to the US Food and Drug Administration. This article discusses information regarding the ownership and other business related aspects of filing a 510(k).
MARKETS
How to Establish and Sustain a Joint Venture in China
P. Lee
Joint ventures with Chinese companies provide one of the most effective ways for international companies to establish a foothold in the booming Chinese economy. The benefits, opportunities and challenges of establishing a joint venture are explored here. Current partnering trends and successful Sino-foreign joint ventures in the fast-growing medical device industry in China are also highlighted.
The Squeeze Goes On
P. Rouard
French manufacturers are seriously challenged by an unfair system for evaluating their products. A new working group is being established to determine some reference methods for the process.
THE INTERVIEW
The MDT Five-Minute Interview
Medical Device Technology’s (MDT)
series of short interviews offers a variety of personal perspectives on the diverse and dynamic medical device technology industry. Here, we talk to Markus Weder.
THIS ISSUE
Developments Across the Industry
• Drug-eluting stent guidance
• Increasing commercial opportunities
• Light and sound detection
• Slow growth in medtech prices
• Online sterilisation standards
• Mixed projections for France
|